M1032 – Adults currently taking pharmacotherapy for oud
HCPCS Level II code · M codes: Medical Services and Quality Measures
HCPCS codeM1032
- Long description
- Adults currently taking pharmacotherapy for oud
- Short description
- Adt tkng pharmthry for oud
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2019
- Last change
- January 1, 2019 – No change
Frequently asked questions
What is HCPCS code M1032?
M1032 is a HCPCS Level II code for adults currently taking pharmacotherapy for oud.
Does Medicare cover M1032?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby M codes
- M1024 – Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five
- M1025 – Patients who were in hospice at any time during the performance period
- M1026 – Patients who were in hospice at any time during the performance period
- M1027 – Imaging of the head (ct or mri) was obtained
- M1028 – Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
- M1029 – Imaging of the head (ct or mri) was not obtained, reason not given
- M1030 – Patients with clinical indications for imaging of the head
- M1031 – Patients with no clinical indications for imaging of the head
- M1033 – Pharmacotherapy for oud initiated after june 30th of performance period
- M1034 – Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
- M1035 – Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
- M1036 – Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
- M1037 – Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
- M1038 – Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
- M1039 – Patients with a diagnosis of lumbar spine region infection at the time of the procedure
- M1040 – Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.